Omega Therapeutics Inc (NASDAQ:OMGA) has a beta value of 1.63 and has seen 5.89 million shares traded in the last trading session. The company, currently valued at $11.68M, closed the last trade at $0.21 per share which meant it lost -$0.02 on the day or -8.14% during that session. The OMGA stock price is -2023.81% off its 52-week high price of $4.46 and 52.38% above the 52-week low of $0.10.
The consensus among analysts is that Omega Therapeutics Inc (OMGA) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.28.
Omega Therapeutics Inc (NASDAQ:OMGA) trade information
Sporting -8.14% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the OMGA stock price touched $0.21 or saw a rise of 23.69%. Year-to-date, Omega Therapeutics Inc shares have moved -71.69%, while the 5-day performance has seen it change 95.46%. Over the past 30 days, the shares of Omega Therapeutics Inc (NASDAQ:OMGA) have changed -62.72%.
Wall Street analysts have a consensus price target for the stock at $9, which means that the shares’ value could jump 97.67% from current levels. The projected low price target is $7.0 while the price target rests at a high of $11.0. In that case, then, we find that the current price level is -5138.1% off the targeted high while a plunge would see the stock gain -3233.33% from current levels.
Omega Therapeutics Inc (OMGA) estimates and forecasts
The company’s shares have lost -86.20% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 100.19%.
1 analysts offering their estimates for the company have set an average revenue estimate of 850k for the current quarter. 1 have an estimated revenue figure of 850k for the next ending quarter. Year-ago sales stood 989k and 2.36M respectively for this quarter and the next, and analysts expect sales will shrink by -14.05% for the current quarter and 100.19% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -48.08% over the past 5 years.
OMGA Dividends
Omega Therapeutics Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Omega Therapeutics Inc (NASDAQ:OMGA)’s Major holders
The top two institutional holders are FLAGSHIP PIONEERING INC. with over 29.23 million shares worth more than $60.5 million. As of 2024-06-30, FLAGSHIP PIONEERING INC. held 52.9924% of shares outstanding.
The other major institutional holder is FMR LLC, with the holding of over 6.24 million shares as of 2024-06-30. The firm’s total holdings are worth over $12.92 million and represent 11.3181% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Growth Company Fund and Vanguard Total Stock Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 3.55% shares in the company for having 1.97 shares of worth $0.42 million while later fund manager owns 779.1 shares of worth $0.16 million as of Sep 30, 2024 , which makes it owner of about 1.41% of company’s outstanding stock.
